These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1862 related items for PubMed ID: 18310456

  • 21. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha.
    Li W, Yu B, Li M, Sun D, Hu Y, Zhao M, Cui CB, Hou S.
    Biochem Biophys Res Commun; 2010 Jan 08; 391(2):1228-33. PubMed ID: 20006586
    [Abstract] [Full Text] [Related]

  • 22. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y, Otsuka F, Hino J, Miyoshi T, Takano M, Miyazato M, Makino H, Kangawa K.
    Mol Cell Endocrinol; 2012 Mar 05; 350(1):78-86. PubMed ID: 22155034
    [Abstract] [Full Text] [Related]

  • 23. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.
    Arthritis Res Ther; 2006 Mar 05; 8(5):R146. PubMed ID: 16945157
    [Abstract] [Full Text] [Related]

  • 24. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN.
    J Bone Miner Res; 2007 May 05; 22(5):646-55. PubMed ID: 17266397
    [Abstract] [Full Text] [Related]

  • 25. Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway.
    Hsu YL, Liang HL, Hung CH, Kuo PL.
    Mol Nutr Food Res; 2009 Nov 05; 53(11):1452-61. PubMed ID: 19784998
    [Abstract] [Full Text] [Related]

  • 26. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY, Kim BC, Lee HS.
    Transl Res; 2008 Jan 05; 151(1):27-35. PubMed ID: 18061125
    [Abstract] [Full Text] [Related]

  • 27. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D.
    Cancer Res; 2006 Feb 01; 66(3):1320-6. PubMed ID: 16452185
    [Abstract] [Full Text] [Related]

  • 28. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM.
    J Cell Biochem; 1999 Apr 01; 73(1):114-25. PubMed ID: 10088730
    [Abstract] [Full Text] [Related]

  • 29. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH, Yang RS, Chien MY, Chen CC, Fu WM.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):40-9. PubMed ID: 17980360
    [Abstract] [Full Text] [Related]

  • 30. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, Teruya T, Nagai K, Chung UI, Yagasaki K, Woo JT.
    Biochem Biophys Res Commun; 2011 Jun 03; 409(2):260-5. PubMed ID: 21570953
    [Abstract] [Full Text] [Related]

  • 31. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K, Zhang L, Jin T, Rutherford RB.
    Cells Tissues Organs; 2004 Jun 03; 176(1-3):28-40. PubMed ID: 14745233
    [Abstract] [Full Text] [Related]

  • 32. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
    Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J.
    J Bone Miner Res; 2003 Nov 03; 18(11):2060-8. PubMed ID: 14606520
    [Abstract] [Full Text] [Related]

  • 33. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
    Lou J, Tu Y, Li S, Manske PR.
    Biochem Biophys Res Commun; 2000 Feb 24; 268(3):757-62. PubMed ID: 10679278
    [Abstract] [Full Text] [Related]

  • 34. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J, Osses N, Brandan E.
    J Cell Physiol; 2006 Jan 24; 206(1):58-67. PubMed ID: 15920756
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR, Viñals F, Ho PW, Gillespie MT, Martin TJ, Ventura F.
    J Cell Physiol; 2008 Jul 24; 216(1):144-52. PubMed ID: 18247361
    [Abstract] [Full Text] [Related]

  • 37. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
    Ho AW, Wong CK, Lam CW.
    Immunobiology; 2008 Jul 24; 213(7):533-44. PubMed ID: 18656701
    [Abstract] [Full Text] [Related]

  • 38. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
    Kong XH, Niu YB, Song XM, Zhao DD, Wang J, Wu XL, Zhang R, Mei QB.
    Int J Mol Med; 2012 Jun 24; 29(6):1090-8. PubMed ID: 22426655
    [Abstract] [Full Text] [Related]

  • 39. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tujisawa T, Nishihara T.
    J Cell Physiol; 2008 Sep 24; 216(3):844-50. PubMed ID: 18449905
    [Abstract] [Full Text] [Related]

  • 40. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R, Koike T, Imai Y, Nomura-Furuwatari C, Takaoka K.
    Bone; 2006 Feb 24; 38(2):206-14. PubMed ID: 16203197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 94.